Get started
Author

Mikhaila L. Rice

Observed names: Mikhaila L Rice, Mikhaila Rice
Institution: Cleveland Clinic
ORCID: 0000-0002-4273-5780
Observed ORCID: 0000-0002-4273-5780
OpenAlex ID: A5040076242
A Five-Component Biginelli-Diels-Alder Cascade Reaction
2018 · Taber S. Maskrey, Madeline C. Frischling, et al. · Frontiers in Chemistry · 20
PDF
Pharmacy Personnel’s Involvement in Transitions of Care of Intensive Care Unit Patients: A Systematic Review
2020 · Mikhaila Rice, Alyssa Lear, et al. · Journal of Pharmacy Practice · 14
Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma
2025 · James A. Davis, Jordan Snyder, et al. · Blood Cancer Journal · 12
Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy
2024 · Danai Dima, Utkarsh Goel, et al. · Hematological Oncology · 7
PDF
Development and validation of a model to predict acute kidney injury following high‐dose methotrexate in patients with lymphoma
2023 · Mikhaila L. Rice, Erin F. Barreto, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 7
Outcomes of BCMA-Directed Chimeric Antigen Receptor T-Cell (CART) Therapy in Patients with Relapse-Refractory Multiple Myeloma with Extramedullary Disease
2023 · Danai Dima, James A Davis, et al. · Blood · 7
Development of an Endothelial Activation and Stress Index (EASIX)-based predictive model for cytokine release syndrome and neurotoxicity after B-cell maturation antigen directed chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma
2025 · Utkarsh Goel, Danai Dima, et al. · Bone Marrow Transplantation · 4
Defining a small-molecule stimulator of the human Hsp70-disaggregase system with selectivity for DnaJB proteins
2024 · Edward Chuang, Ryan R. Cupo, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4
PDF
Assessment of gender differences in letters of recommendation for pharmacy residency applicants
2021 · Mikhaila L Rice, Jonathan G Leung, et al. · American Journal of Health-System Pharmacy · 4
Dexamethasone for management of cytokine release syndrome (CRS) associated with talquetamab in patients with Relapsed/Refractory multiple myeloma
2025 · Jessica McElwee, Grace Elsey, et al. · Blood · 3
PDF
Management of relapsed refractory multiple myeloma: Evidence-based guide to community oncologists
2025 · Ali Mushtaq, Asfand Yar Cheema, et al. · Blood Reviews · 3
Dexamethasone for the Management of CRS Related to Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma
2024 · James A Davis, Jordan Snyder, et al. · Blood · 3
PDF
Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction‐based diagnosis in patients receiving bendamustine
2021 · Mikhaila L. Rice, Jason N. Barreto, et al. · Cancer Medicine · 3
PDF
Supportive care alone is effective for managing low-grade CRS in multiple myeloma patients treated with bispecific antibodies
2025 · Victoria Nachar, Iman Ahmed, et al. · Blood · 2
PDF
Incidence of CMV-reactivation in multiple myeloma patients receiving bispecific antibodies
2025 · Jordan Snyder, Dennis Grauer, et al. · Blood · 1
PDF
Real-World Practice in the Management of Transplant-Eligible Newly Diagnosed Multiple Myeloma: A US-Based Cross-Sectional National Survey
2025 · Hossam M. Ali, Zainab Yusufali Motiwala, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
P-256 Initial report of a single institution experience with teclistamab for relapsed or refractory multiple myeloma including prior BCMA
2023 · Beth Faiman, Danai Dima, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Validation of the Gatmo Score in Predicting Mortality Following Autologous Hematopoietic Cell Transplant in Multiple Myeloma Patients
2022 · Hussein Awada, Adel Hajj Ali, et al. · Blood · 1
Unexpected Vancomycin Pharmacokinetic Profile Secondary to Macromolecular Complexing: A Case Series
2021 · Mikhaila L. Rice, John Raymond Go, et al. · Therapeutic Drug Monitoring · 1
NSP-17 Initial Experiences of Outpatient Bispecific Antibody Administration at a Large Academic Center
2026 · Beth Faiman, Mikhaila Rice, et al. · Clinical Lymphoma Myeloma & Leukemia
PA-045 BCMA Bispecific Antibodies in Relapsed AL Amyloidosis: A Retrospective Cohort Study
2026 · Vasil Mico, Xia Wu, et al. · Clinical Lymphoma Myeloma & Leukemia
Dexamethasone for Management of Cytokine Release Syndrome Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma
2026 · Jessica McElwee, Grace Elsey, et al. · American Journal of Hematology
Condensed vs. Standard Step‐Up Dosing Schedule of Talquetamab in Relapsed/Refractory Multiple Myeloma
2026 · Grace Elsey, James A. Davis, et al. · European Journal Of Haematology
PDF
Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort
2026 · Hossam M. Ali, Sandra Mazzoni, et al. · Blood Cancer Journal
PDF
Pharmacist Perspectives on High-Dose Methotrexate Management and Acute Kidney Injury Risk Mitigation in Patients With Lymphoma: Results From a National Survey
2026 · Elizabeth B. King, Mikhaila L. Rice, et al. · Journal of Pharmacy Practice
Works count: 39
Citation count: 98
H-index: 6
I10-index: 3
Year
Topic
Type